Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026)
Perspective Therapeutics (CATX) posted Receivables - Net of $58000.0 for Q1 2026, up 866.67% sequentially from $6000.0 in Q4 2025, and down 25.64% YoY from $78000.0 in Q1 2025.
Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Receivables - Net for 16 years, with the latest figure at $58000.0 in Q1 2026.
- Quarterly Receivables - Net fell 25.64% year-over-year to $58000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58000.0 (down 25.64% YoY) and the FY2025 annual result came in at $6000.0, down 94.83% from the prior year.
- Receivables - Net grew to $58000.0 in Q1 2026 per CATX's latest filing, from $6000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $2.1 million in Q1 2022 and troughed at $6000.0 in Q4 2025.
- A 5-year average of $806882.4 and a median of $999000.0 in 2024 frame the typical range for Receivables - Net.
- The widest YoY moves for Receivables - Net: up 58.45% in 2025, down 94.83% in 2025.
- Over 5 years, Receivables - Net stood at $1.4 million in 2022, then dropped by 14.53% to $1.2 million in 2023, then plunged by 90.04% to $116000.0 in 2024, then sank by 94.83% to $6000.0 in 2025, then jumped by 866.67% to $58000.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $58000.0, $6000.0, and $179000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 387.28 Mn | 387.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 269,000.00 |
| Jun 30, 2026 | 269,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Mar 31, 2024 | 999,000.00 |